Skip to content

Clinical trials

Withdrawn Fatty Liver trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Status: Withdrawn Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20121
20131
20141
20151
20161
20172
20181
20194
20201
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sagimet Biosciences Inc.2
Aaron Fenster1
Arkansas Children's Hospital Research Institute1
Columbia University1
Fibronostics USA, Inc1
Gyongyi Szabo1
Immuron Ltd.1
Medical College of Wisconsin1
Methodist Health System1
Milton S. Hershey Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver21
Non-alcoholic Fatty Liver Disease12
Fibrosis3
Diabetes Mellitus2
Obesity2
Body Weight Changes1
Burns1
Diabetes Mellitus, Type 21
Glucose Intolerance1
Heart Failure1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.